PM360 Announces 2025 Lifetime Achievement Award winner

Recipient to be honored at Trailblazer Award Gala at NYC's Gotham Hall, September 30

NEW YORK, June 25, 2025 /PRNewswire/ -- PM360 is honored to announce its Lifetime Achievement Recipient—Dr. Sol J. Barer of Teva Pharmaceuticals—who will be recognized at the 17th annual Trailblazer Awards in NYC on September 30.

PM360—a leading life sciences marketing industry trade publication—established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

Dr. Barer was nominated by Fred Hassan of the Cataret Group, a past recipient of the Lifetime Achievement Award and previously the Board Chairman & CEO of Pharmacia & Upjohn, Schering-Plough, and Board Chairman of Bausch & Lomb.

"Dr. Barer is a great selection for PM360's Trailblazer Lifetime Achievement Award," Fred Hassan said, regarding Dr. Barer's transformative leadership in the biotechnology sector. "Not only is he a brilliant scientist and entrepreneur, he is [also] a very good human being."

Dr. Barer is best known for his pivotal role at Celgene Corporation, where he served as Chairman and CEO. He was also the founder of the biotechnology group at Celanese Research, which later became Celgene, making a significant mark on the global biotech landscape.

Currently, Dr. Barer chairs the boards of Teva Pharmaceutical Industries, Centrexion, and the HMH Center for Discovery and Innovation. His entrepreneurial spirit extends to his involvement with MIG, an organization that supports Israeli biotech ventures, and his role as a Venture Advisor to the Israel Biotechnology Fund. He is deeply committed to advancing education and policy, having led the University of Medicine and Dentistry of New Jersey's Governor's Advisory Committee and serving on various boards, including Rutgers University and BioNJ.

Dr. Barer's remarkable contributions have earned him widespread recognition, including being named to Scientific American's "Worldview 100," and honored with multiple awards such as the 'Outstanding Global Director' by the Financial Times and the "Lifetime Achievement Award" from the International Myeloma Foundation. He is also celebrated for his philanthropic efforts, receiving accolades for his community service from organizations such as Rambam Healthcare Center in Israel and Overlook Hospital.

In addition to his professional accomplishments, Dr. Barer holds a Ph.D. in Organic Chemistry from Rutgers University and has received an honorary LL.D. from the Rabbinical College of America. He and his wife, Meri, have been married for 56 years and are proud parents of four children and fifteen grandchildren.

About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Contact:
Gabrielle Smith, Editor
646-300-8113
[email protected]

Gabriela L. Laracca, Editor
646-300-8114
[email protected]

SOURCE PM360